Cofilin promotes tau pathology in Alzheimer's disease

Cell Rep. 2023 Feb 28;42(2):112138. doi: 10.1016/j.celrep.2023.112138. Epub 2023 Feb 17.

Abstract

The molecular mechanisms mediating the aggregation and transmission of tau in AD remain unclear. Here, we show that the actin-binding protein cofilin is cleaved by a cysteine protease asparagine endopeptidase (AEP) at N138 in the brains of patients with AD. The AEP-generated cofilin 1-138 fragment interacts with tau and promotes its aggregation. The mixed fibrils consisting of cofilin 1-138 and tau are more pathogenic to cells than pure tau fibrils. Furthermore, overexpression of cofilin 1-138 in the brain facilitates the propagation of pathological tau aggregates and promotes AD-like cognitive impairments in tau P301S mice. However, mice infected with adeno-associated viruses (AAVs) encoding an AEP-uncleavable cofilin mutant show attenuated tau pathology and cognitive impairments compared with mice injected with AAVs encoding wild-type cofilin. Together, these observations support the role of the cofilin 1-138 fragment in the aggregation and transmission of tau pathology during the onset and progression of AD.

Keywords: Alzheimer’s disease; CP: Neuroscience; cofilin; cognitive impairments; legumain; tau.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Actin Depolymerizing Factors / metabolism
  • Alzheimer Disease* / metabolism
  • Animals
  • Brain / metabolism
  • Cofilin 1 / metabolism
  • Disease Models, Animal
  • Humans
  • Mice
  • Mice, Transgenic
  • tau Proteins / metabolism

Substances

  • Actin Depolymerizing Factors
  • Cofilin 1
  • tau Proteins
  • MAPT protein, human